192 related articles for article (PubMed ID: 19106248)
1. ALCAT1 is a polyglycerophospholipid acyltransferase potently regulated by adenine nucleotide and thyroid status.
Cao J; Shen W; Chang Z; Shi Y
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E647-53. PubMed ID: 19106248
[TBL] [Abstract][Full Text] [Related]
2. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse.
Cao J; Liu Y; Lockwood J; Burn P; Shi Y
J Biol Chem; 2004 Jul; 279(30):31727-34. PubMed ID: 15152008
[TBL] [Abstract][Full Text] [Related]
3. Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression.
Li J; Liu X; Wang H; Zhang W; Chan DC; Shi Y
Proc Natl Acad Sci U S A; 2012 May; 109(18):6975-80. PubMed ID: 22509026
[TBL] [Abstract][Full Text] [Related]
4. The microsomal cardiolipin remodeling enzyme acyl-CoA lysocardiolipin acyltransferase is an acyltransferase of multiple anionic lysophospholipids.
Zhao Y; Chen YQ; Li S; Konrad RJ; Cao G
J Lipid Res; 2009 May; 50(5):945-56. PubMed ID: 19075029
[TBL] [Abstract][Full Text] [Related]
5. Ablation of ALCAT1 mitigates hypertrophic cardiomyopathy through effects on oxidative stress and mitophagy.
Liu X; Ye B; Miller S; Yuan H; Zhang H; Tian L; Nie J; Imae R; Arai H; Li Y; Cheng Z; Shi Y
Mol Cell Biol; 2012 Nov; 32(21):4493-504. PubMed ID: 22949503
[TBL] [Abstract][Full Text] [Related]
6. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis.
Wang L; Liu X; Nie J; Zhang J; Kimball SR; Zhang H; Zhang WJ; Jefferson LS; Cheng Z; Ji Q; Shi Y
Hepatology; 2015 Feb; 61(2):486-96. PubMed ID: 25203315
[TBL] [Abstract][Full Text] [Related]
7. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity.
Li J; Romestaing C; Han X; Li Y; Hao X; Wu Y; Sun C; Liu X; Jefferson LS; Xiong J; Lanoue KF; Chang Z; Lynch CJ; Wang H; Shi Y
Cell Metab; 2010 Aug; 12(2):154-65. PubMed ID: 20674860
[TBL] [Abstract][Full Text] [Related]
8. Cardiolipin remodeling by ALCAT1 links hypoxia to coronary artery disease by promoting mitochondrial dysfunction.
Jia D; Zhang J; Nie J; Andersen JP; Rendon S; Zheng Y; Liu X; Tian Z; Shi Y
Mol Ther; 2021 Dec; 29(12):3498-3511. PubMed ID: 34111561
[TBL] [Abstract][Full Text] [Related]
9. LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1.
Zou C; Synan MJ; Li J; Xiong S; Manni ML; Liu Y; Chen BB; Zhao Y; Shiva S; Tyurina YY; Jiang J; Lee JS; Das S; Ray A; Ray P; Kagan VE; Mallampalli RK
J Cell Sci; 2016 Jan; 129(1):51-64. PubMed ID: 26604221
[TBL] [Abstract][Full Text] [Related]
10. Cardiolipin remodeling by ALCAT1 links mitochondrial dysfunction to Parkinson's diseases.
Song C; Zhang J; Qi S; Liu Z; Zhang X; Zheng Y; Andersen JP; Zhang W; Strong R; Martinez PA; Musi N; Nie J; Shi Y
Aging Cell; 2019 Jun; 18(3):e12941. PubMed ID: 30838774
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of biotinylated-LPG as a chemical biology tool enabling discovery of ALCAT1 modulators.
Huang H; Zhou R; Wen H; Xu Z; Zhang S; Wang W; Krosky D; Miller R
Bioorg Med Chem Lett; 2022 Sep; 72():128861. PubMed ID: 35718103
[TBL] [Abstract][Full Text] [Related]
12. The effects of chronic muscle use and disuse on cardiolipin metabolism.
Ostojic O; O'Leary MF; Singh K; Menzies KJ; Vainshtein A; Hood DA
J Appl Physiol (1985); 2013 Feb; 114(4):444-52. PubMed ID: 23221956
[TBL] [Abstract][Full Text] [Related]
13. ALCAT1-mediated abnormal cardiolipin remodelling promotes mitochondrial injury in podocytes in diabetic kidney disease.
Hao Y; Fan Y; Feng J; Zhu Z; Luo Z; Hu H; Li W; Yang H; Ding G
Cell Commun Signal; 2024 Jan; 22(1):26. PubMed ID: 38200543
[TBL] [Abstract][Full Text] [Related]
14. In Search of the Holy Grail: Toward a Unified Hypothesis on Mitochondrial Dysfunction in Age-Related Diseases.
Zhang J; Shi Y
Cells; 2022 Jun; 11(12):. PubMed ID: 35741033
[TBL] [Abstract][Full Text] [Related]
15. An upstream open reading frame (5'-uORF) links oxidative stress to translational control of ALCAT1 through phosphorylation of eIF2α.
Zhang J; Shi Y
Free Radic Biol Med; 2024 Mar; 214():129-136. PubMed ID: 38360278
[TBL] [Abstract][Full Text] [Related]
16. A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling.
Nie J; Hao X; Chen D; Han X; Chang Z; Shi Y
Biochim Biophys Acta; 2010 Apr; 1801(4):438-45. PubMed ID: 20025994
[TBL] [Abstract][Full Text] [Related]
17. ALCAT1 Overexpression Affects Supercomplex Formation and Increases ROS in Respiring Mitochondria.
Rieger B; Krajčová A; Duwe P; Busch KB
Oxid Med Cell Longev; 2019; 2019():9186469. PubMed ID: 31885824
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection Attributed to Aerobic Exercise-Mediated Inhibition of ALCAT1 and Oxidative Stress-Induced Apoptosis in MI Rats.
Liu N; Zhu Y; Song W; Ren W; Tian Z
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140351
[TBL] [Abstract][Full Text] [Related]
19. Expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart.
Taylor WA; Xu FY; Ma BJ; Mutter TC; Dolinsky VW; Hatch GM
BMC Biochem; 2002 May; 3():9. PubMed ID: 12019031
[TBL] [Abstract][Full Text] [Related]
20. A tail of their own: regulation of cardiolipin and phosphatidylinositol fatty acyl profile by the acyltransferase LCLAT1.
Zhang K; Chan V; Botelho RJ; Antonescu CN
Biochem Soc Trans; 2023 Oct; 51(5):1765-1776. PubMed ID: 37737061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
